ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

NCI, ACS, Health Departments Launch ASSIST, Goal To Cut US Smoking Rate In Half By Yr 2000

October 11, 1991

Radiotherapy Provides Longer Life To Brain Cancer Patients

May 28, 2010

Funding Opportunities: ACS Calif. Division Calls for Applications

August 1, 1997

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

November 27, 1987

Also in this 8-page issue: Tony Hunter, Raymond DuBois win AACR Landon prizes.

March 5, 2004

NCI Plans Research To Reduce Cancer Disparities.

June 16, 2000